Gender differences among patients with secondary hyperparathyroidism undergoing parathyroidectomy

Journal of Surgical Research

Volumn 168, Issue 1, 2011, Pages 82-87

  Cheng, Shih Ping ^a,c   Yang, Tsen Long ^a,b   Lee, Jie Jen ^a,d   Chen, Han Hsiang ^a,b   Wu, Chih Jen ^a,b,d   Liu, Tsang Pai ^a,b   Liu, Chien Liang ^a,b  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

chronic kidney disease; gender; parathyroidectomy; secondary hyperparathyroidism

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; CALCIUM; HEMOGLOBIN; PARATHYROID HORMONE; PHOSPHORUS;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE DENSITY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PARATHYROIDECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECURRENCE RISK; SECONDARY HYPERPARATHYROIDISM; SEX DIFFERENCE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BONE DENSITY; FEMALE; HEMOGLOBINS; HUMANS; HYPERPARATHYROIDISM, SECONDARY; MALE; MIDDLE AGED; PARATHYROID HORMONE; PARATHYROIDECTOMY; PROSPECTIVE STUDIES; RECURRENCE; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79955586934     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.07.034     Document Type: Article

References (30)

1. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42:S1.
2. Goodman WG, Quarles LD. Development and progression of secondary hyperparathyroidism in chronic kidney disease: Lessons from molecular genetics. Kidney Int 2008;74:276.
3. Moe S, Drueke T, Cunningham J, et al. Kidney disease: Improving global outcomes (KDIGO). Definition, evaluation, and classification of renal osteodystrophy: A position statement from kidney disease: Improving global outcomes (KDIGO). Kidney Int 2006;69:1945.
4. Slinin Y, Foley RN, Collins AJ. Clinical epidemiology of parathyroidectomy in hemodialysis patients: The USRDS waves 1, 3, and 4 study. Hemodial Int 2007;11:62.
5. Foley RN, Li S, Liu J, et al. The fall and rise of parathyroidectomy in U.S. hemodialysis patients, 1992 to 2002. J Am Soc Nephrol 2005;16:210.
6. Malberti F, Marcelli D, Conte F, et al. Parathyroidectomy in patients on renal replacement therapy: An epidemiologic study. J Am Soc Nephrol 2001;12:1242.
7. Kestenbaum B, Seliger SL, Gillen DL, et al. Parathyroidectomy rates among United States dialysis patients: 1990-1999. Kidney Int 2004;65:282.
8. Miller BS, Dimick J, Wainess R, et al. Age- and sex-related incidence of surgically treated primary hyperparathyroidism. World J Surg 2008;32:795.
9. Indridason OS, Pieper CF, Quarles LD. Predictors of short-term changes in serum intact parathyroid hormone levels in hemodialysis patients: Role of phosphorus, calcium, and gender. J Clin Endocrinol Metab 1998;83:3860.
10. Gupta A, Kallenbach LR, Zasuwa G, et al. Race is a major determinant of secondary hyperparathyroidism in uremic patients. J Am Soc Nephrol 2000;11:330.
11. Fan SL, Chan A, Raftery MJ, et al. Race and sex: Predictors of the severity of hyperparathyroidism in peritoneal dialysis patients. Nephrology (Carlton) 2006;11:15.
12. Almaden Y, Felsenfeld AJ, Rodriguez M, et al. Proliferation in hyperplastic human and normal rat parathyroid glands: Role of phosphate, calcitriol, and gender. Kidney Int 2003;64:2311.
13. Lomonte C, Cazzato F, Casucci F, et al. Female hemodialysis patients have an increased risk of nodular hyperplasia of parathyroid glands. J Nephrol 2005;18:92.
14. Basile C, Lomonte C, Vernaglione L, et al. A high body mass index and female gender are associated with an increased risk of nodular hyperplasia of parathyroid glands in chronic uraemia. Nephrol Dial Transplant 2006;21:968.
15. Lomonte C, Vernaglione L, Cazzato F, et al. Post-parathyroidectomy serum phosphate kinetics is peculiar to female hemodialysis patients with a high body mass index. J Nephrol 2006;19:70.
16. Tominaga Y, Matsuoka S, Sato T. Surgical indications and procedures of parathyroidectomy in patients with chronic kidney disease. Ther Apher Dial 2005;9:44.
17. Cheng SP, Liu CL, Chen HH, et al. Prolonged hospital stay after parathyroidectomy for secondary hyperparathyroidism. World J Surg 2009;33:72.
18. Haden ST, Brown EM, Hurwitz S, et al. The effects of age and gender on parathyroid hormone dynamics. Clin Endocrinol (Oxf) 2000;52:329.
19. Pazianas M, Phillips ME, MacRae KD, et al. Identification of risk factors for radiographic hyperparathyroidism in 422 patients with end-stage renal disease:Development of a clinical predictive index. Nephrol Dial Transplant 1992;7:1098.
20. Luisetto G, Bertoli M. Sexual influence on bone metabolism in uremic patients on regular dialytic treatment. Nephron 1994;67:150.
21. Taal MW, Masud T, Green D, et al. Risk factors for reduced bone density in hemodialysis patients. Nephrol Dial Transplant 1999;14:1922.
22. Stein MS, Packham DK, Ebeling PR, et al. Prevalence and risk factors for osteopenia in dialysis patients. Am J Kidney Dis 1996;28:515.
23. Riggs BL, Khosla S, Melton LJ, III. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 2002;23:279.
24. Khosla S, Atkinson EJ, Melton LJ, III, et al. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: A population-based study. J Clin Endocrinol Metab 1997;82:1522.
25. Urena P, Hruby M, Ferreira A, et al. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients. J Am Soc Nephrol 1996;7:506.
26. Brancaccio D, Cozzolino M, Gallieni M. Hyperparathyroidism and anemia in uremic subjects: A combined therapeutic approach. J Am Soc Nephrol 2004;15(Suppl 1):S21.
27. Trunzo JA, McHenry CR, Schulak JA, et al. Effect of parathyroidectomy on anemia and erythropoietin dosing in end-stage renal disease patients with hyperparathyroidism. Surgery 2008;144:915.
28. Chow TL, Chan TT, Ho YW, et al. Improvement of anemia after parathyroidectomy in Chinese patients with renal failure undergoing long-term dialysis. Arch Surg 2007;142:644.
29. Gallieni M, Corsi C, Brancaccio D. Hyperparathyroidism and anemia in renal failure. Am J Nephrol 2000;20:89.
30. Nakajima K, Umino K, Azuma Y, et al. Stimulating parathyroid cell proliferation and PTH release with phosphate in organ cultures obtained from patients with primary and secondary hyperparathyroidism for a prolonged period. J Bone Miner Metab 2009;27:224.